Inventor
YELLIN MICHAEL J
US12 patents
⚠️ This page may combine multiple inventors who share the name “YELLIN MICHAEL J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV COLUMBIA
11 patentsUS5474771ADec 12, 1995
Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of T-lymphocytes, compositions containing same
UNIV COLUMBIA152 citations98
US6793924B2Sep 21, 2004
Protein recognized by an antibody that specifically binds an epitope that is specifically bound by monoclonal antibody 5c8.
UNIV COLUMBIA31 citations96
US6610294B1Aug 26, 2003
Methods of inhibiting an autoimmune response in a human suffering from an autoimmune disease by administering an antibody that binds to a protein to which monoclonal antibody 5C8 binds
UNIV COLUMBIA36 citations96
US6592868B1Jul 15, 2003
Methods for treating autoimmune diseases with 5C8-specific antibodies
UNIV COLUMBIA33 citations96
US6455044B1Sep 24, 2002
5c8 antigen
UNIV COLUMBIA33 citations96
US6451310B1Sep 17, 2002
Method for inhibiting an allergic response with a 5c8-specific antibody
UNIV COLUMBIA41 citations96
US6403091B1Jun 11, 2002
Methods for inhibiting the rejection of a transplant organ in a subject with 5C8-specific antibodies
UNIV COLUMBIA42 citations96
US6340459B1Jan 22, 2002
Therapeutic applications for the anti-T-BAM (CD40-L) monoclonal antibody 5C8 in the treatment of reperfusion injury in non-transplant recipients
UNIV COLUMBIA53 citations96
US7070777B1Jul 4, 2006
Method for inhibiting inflammation with an antibody that binds the 5C8 protein
UNIV COLUMBIA15 citations84
US6331615B1Dec 18, 2001
Nucleic acid molecule encoding heavy or light chain of an antibody which specifically recognizes a protein specifically recognized by monoclonal antibody 5c8 (anti-CD40 ligand)
UNIV COLUMBIA10 citations82
US6331433B1Dec 18, 2001
Human T cell leukemia cell line designated D1.1
UNIV COLUMBIA10 citations82